Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

ReNeuron Group PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

18 Apr 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - RENEURON GROUP PLC (RENE-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Apr 2015 Thomson Reuters Stock Report 10 $25.00

RENEURON GROUP - SUPPORTIVE PISCES DATA

ReNeuron presented two-year follow-up data from the PISCES study in disabled stroke patients, which confirm the potential for...

23 Apr 2015 Edison Investment Research 7 $10.00

ReNeuron Group plc (RENE) - Financial and Strategic SWOT Analysis Review

ReNeuron Group plc (RENE) - Financial and Strategic SWOT Analysis Review Summary ReNeuron Group plc (ReNeuron) is a clinical-...

07 Apr 2015 GlobalData 47 $125.00

Wright Investors Service Comprehensive Report for Reneuron Group PLC

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

20 Mar 2015 Wright Reports 55 $75.00

Is ReNeuron Group Plc a Gamble?

02 Mar 2015 Sadif Analytics Prime 12 $25.00

Company Snapshot - ReNeuron Group

Two Directors at ReNeuron Group bought/maiden bought 484,334 shares at 3.10p. The significance rating of the trade was 53/100...

30 Jan 2015 Directors Deals Ltd. 1 $12.00

ReNeuron Group plc (RENE) - Financial and Strategic SWOT Analysis Review

ReNeuron Group plc (RENE) - Financial and Strategic SWOT Analysis Review Summary ReNeuron Group plc (ReNeuron) is a clinical-...

06 Jan 2015 GlobalData 45 $125.00

ReNeuron Group Plc: Upgraded to Above Average

18 Dec 2014 Sadif Analytics Prime 3 $10.00

RENEURON - POISED FOR A PIVOTAL YEAR

ReNeuron is facing a potentially transformational year in 2015, with key clinical data and relocation to a new cell manufactu...

28 Nov 2014 Edison Investment Research 3 $10.00